BLIS Technologies (BLT) Stock Overview

BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company markets two strains of probiotic bacteria, which include BLIS K12, a probiotic supplement to support ear, nose, and throat health of young children, as well as for improving immunity and bad breath; BLIS M18, an oral probiotic to support teeth, gums, and dental health; and BLIS Q24, a probiotic supplement to balance and restore the skin microbiome, restoring the health, clarity, and radiance. It has operations in New Zealand, Asia Pacific, Europe, the Middle East, Africa, and North America. The company was incorporated in 2000 and is based in Dunedin, New Zealand.

BLT Stock Information

Symbol

BLT

Address

442 Moray PlaceDunedin, 9016New Zealand

Founded

Trading hours

Website

https://www.blis.co.nz

Country

🇳🇿 New Zealand

Phone Number

64 3 474 0988

BLIS Technologies (BLT) Price Chart

BLIS Technologies Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.01116895526833415	N/A
Market Cap	$14.23M	N/A
Shares Outstanding	1.27B	3.56%
Employees	45.00	N/A
Shareholder Equity	10.84M	-10.81%

Valuation	2023	Change
P/E Ratio	-10.15	N/A
P/S Ratio	2.30	N/A
P/B Ratio	1.31	N/A
P/FCF	2547.60	N/A

Growth	2023	Change
WACC	0.0172	N/A
CAPEX	-31.02K	N/A
Return on Equity	-0.0773	N/A

Earnings	2023	Change
Revenue	$6.17M	N/A
Earnings	-$837.67K	N/A
Free Cash Flow	$5.58K	N/A
EPS	-0.0011	N/A
Earnings Yield	-0.0985	N/A
Gross Margin	0.7801	N/A
Operating Margin	-0.2435	N/A
Net income margin	-0.1357	N/A
FCF Margin	0.0009	N/A

Financial Strength	2023	Change
Total Assets	$7.95M	N/A
Total Debt	$384.09K	N/A
Cash on Hand	$5.18M	N/A
Debt to Equity	0.1130	11.05%
Cash to Debt	$13.48	18.31%
Current Ratio	$6.86	-11.42%